You are here: Industry Insights > opioid

News List

Oklahoma supreme court overturns ruling against J&J in $465m opioid lawsuit Pharmaceutical-Technology
November 11, 2021
The Oklahoma State Supreme Court in the US has overturned a 2019 judgement that had ruled Johnson & Johnson (J&J) and its Janssen Pharmaceutical Companies accountable for contributing to the opioid crisis.
Florida Receives $4.3M to Help Rehabs Like Legacy Healing Center Combat the Opioid Epidemic prnewswire
November 01, 2021
The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, is set to distribute an additional $4.3 million to organizations ...
FDA approves naloxone injection to counteract opioid overdoses FDA
October 20, 2021
Action: FDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose. ZIMHI is administered using a single-dose, prefilled syringe that delivers 5 milligrams (mg) ...
2019 to 2020 Saw Increase in Benzodiazepine Overdose ED Visits drugs
August 27, 2021
From 2019 to 2020, there was an increase in benzodiazepine overdose emergency department visits and in benzodiazepine deaths, according to research published in the Aug. 27 issue of the U.S. CDC and Prevention Morbidity and Mortality Weekly Report.
Rising Number of U.S. Cardiac Arrests Tied to Opioid Abuse drugs
August 24, 2021
There's been a sharp rise in opioid-related cardiac arrests in the United States and they now equal those associated with other prime causes, a new study finds.
Family Behind Oxycontin Denies Any Responsibility for Opioid Crisis drugs
August 20, 2021
The former president and co-chairman of Purdue Pharma said Wednesday that his family and the company bear no responsibility for the opioid crisis in the United States.
J&J to pay up to $5bn in US opioid settlement europeanpharmaceuticalreview
July 28, 2021
Johnson & Johnson has signed a nationwide opioid settlement agreement and will pay billions to settle opioid-related claims and litigation in the US.
FDA Accepts Braeburn’s New Drug Application Resubmission for Brixadi (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder drugs
July 28, 2021
Braeburn announces that the New Drug Application (NDA) for Brixadi (buprenorphine) extended-release weekly and monthly injection for subcutaneous (SC) use (CIII) for moderate to severe opioid use disorder was accepted by the FDA.
New York, drug distributors reach $1.18 billion opioid settlement as national deal looms expresspharma
July 22, 2021
The three largest US drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nation-wide opioid epidemic, the state’s attorney general said 20th.
Interaxon Partners with Celéri Health to Validate Chronic Pain Intervention prnasia
July 21, 2021
Interaxon, along with Celéri Health and pain expert Dr. Ronald D. Siegel, is testing a therapeutic intervention to help people better manage their chronic and acute pain.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page